Cargando...
The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
Hodgkin Lymphoma (HL) is a unique disease entity both in its pathology and the young patient population that it primarily affects. Although cure rates are high, survivorship can be linked with significant long-term morbidity associated with both chemotherapy and radiotherapy. The most significant re...
Guardado en:
| Publicado en: | Cancers (Basel) |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6025119/ https://ncbi.nlm.nih.gov/pubmed/29914088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10060204 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|